[go: up one dir, main page]

TN2013000209A1 - 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists - Google Patents

4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists

Info

Publication number
TN2013000209A1
TN2013000209A1 TNP2013000209A TN2013000209A TN2013000209A1 TN 2013000209 A1 TN2013000209 A1 TN 2013000209A1 TN P2013000209 A TNP2013000209 A TN P2013000209A TN 2013000209 A TN2013000209 A TN 2013000209A TN 2013000209 A1 TN2013000209 A1 TN 2013000209A1
Authority
TN
Tunisia
Prior art keywords
phenylsulfanylmethyl
mglur
bicyclo
antagonists
substituted
Prior art date
Application number
TNP2013000209A
Other languages
French (fr)
Inventor
Stephon Cornell Smith
Renhua Li
Charles Howard Mitch
Tatiana Natali Vetman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/060730 external-priority patent/WO2012068067A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000209A1 publication Critical patent/TN2013000209A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A mGlu2/3 receptor antagonist of the formula (I):, its uses, and methods for its preparation are described.
TNP2013000209A 2011-11-15 2013-05-14 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists TN2013000209A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/060730 WO2012068067A1 (en) 2010-11-18 2011-11-15 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists

Publications (1)

Publication Number Publication Date
TN2013000209A1 true TN2013000209A1 (en) 2014-11-10

Family

ID=54360709

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000209A TN2013000209A1 (en) 2011-11-15 2013-05-14 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists

Country Status (1)

Country Link
TN (1) TN2013000209A1 (en)

Similar Documents

Publication Publication Date Title
GEP201706745B (en) Forms of rifaximin and usage thereof
GB201017345D0 (en) Receptor antagonists
MY181898A (en) Heterocyclic compounds and uses thereof
MY173521A (en) Trpv4 antagonists
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
AP2012006630A0 (en) Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor
PH12013500991A1 (en) 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGLuR 2/3 ANTAGONISTS
MX2013005623A (en) 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS.
WO2012154879A3 (en) Autophagy inhibitors
PH12013500210A1 (en) Highly crystalline valsartan
PH12012502300A1 (en) Nicotinic receptor non-competitive antagonists
MX341132B (en) (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS.
WO2012139074A3 (en) Migrastatins and uses thereof
TN2013000209A1 (en) 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
MX2013002656A (en) New process.
WO2013067105A3 (en) Nicotinic receptor non-competitive modulators
HK40120913A (en) 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
MX2012013075A (en) Novel methods for the preparation of p2x7r antagonists.
WO2013054273A3 (en) Process for the preparation of agomelatine
WO2012094437A3 (en) Nicotinic receptor non-competitive antagonists
UA54879U (en) Use of antagonist of interleukin-1 receptor as antioxidant agent
UA108500C2 (en) Noncompetitive antagonists of nicotinic receptors
UA51902U (en) use of interleukin-1 receptor antagonists (aryl-1) as frigoprotective agent
PL392583A1 (en) Process for the preparation of 2,3-di(metoxycarbonyl)-5-norbornene
UA74358U (en) Phytotea composition